Warfarin: an old drug but still interesting.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. The Impact of Genetic and Non-Genetic Factors on Warfarin Dose Prediction in MENA Region: A Systematic Review.PloS one · 2016
   Pooled it
2. Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study.Biomedicines · 2023
   Article
3. Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients.European journal of clinical pharmacology · 2019
   Article
4. Pharmacogenomics and personalized medicine · 2019
   Article
5. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.Clinical and experimental nephrology · 2014
   Article
6. Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Current opinion in cardiology · 2013
   Review
7. Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more.Pharmacy practice · 2012
   Article

Corrections and comments

• Commented on by
  Warfarin and pharmacogenomic testing: what would Pascal do?2009
• Comment on
  Warfarin pharmacogenetics.2008
• Comment on
  Discrepancies in identification of major bleeding events in patients taking warfarin.2008

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as